prospidium has been researched along with Hodgkin Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Danova, LA; Gershanovich, ML; Kondrat'ev, VB; Vinokurova, NA | 1 |
| Gubareva, AA; Kindzel'skiĭ, LP | 1 |
2 other study(ies) available for prospidium and Hodgkin Disease
| Article | Year |
|---|---|
[Use of prospidin in the combination chemotherapy of recurrences of generalized forms of lymphogranulomatosis].
Topics: Adult; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Middle Aged; Piperazines; Prednisolone; Prospidium; Recurrence; Vincristine | 1983 |
[Indirect endolymphatic chemotherapy of patients with lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Hodgkin Disease; Humans; Injections, Intralymphatic; Lomustine; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Procarbazine; Prospidium; Remission Induction; Vinblastine; Vincristine | 1989 |